Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-14

Clinical Trial Update: Observational Study of Type 1 Diabetics Switching From Human Insulins to Modern Insulin Analogues

View source ↗

Summary

A completed observational study evaluating outcomes after switching Type 1 diabetes patients from human insulin to modern insulin analogues.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin Glargine (insulin glargine)
  • Insulin aspart (insulin aspart)
  • Insulin detemir (insulin detemir)
  • insulin lispro (insulin lispro)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Status: COMPLETED